bcrmut | 20821
TKI resistance BCR-ABL mutations
Keywords:
BCR-ABL mutations
MPN
imatinib resistance CML
myeloproliferative neoplasms
Status
| Material |
|
||
|---|---|---|---|
| Hint |
There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent). |
||
| Min. volume | 4 mL | ||
| Stability |
Stability
1 day / 2-8°C
|
||
| Duration | 3 days | ||
| Frequency | 2 x per week |
Price/Rate
| Price |
Price
CHF 0.00
|
|---|---|
| Rate |
Rate
0.00 TP
|
Executing laboratory
| External laboratory |
|---|